This indicator measures the proportion of children under five who experienced fever in the two weeks leading up to the survey, specifically focusing on those who received antimalarial medications. It offers critical insights into the accessibility and effectiveness of malaria treatment among young children in regions where the disease is prevalent. By analyzing this data, health officials can identify
gaps in treatment coverage and evaluate the responsiveness of healthcare systems to pediatric care needs. Furthermore, understanding this percentage can help in assessing the overall public health strategies aimed at combating malaria, ensuring that vulnerable populations receive timely and appropriate medical intervention.
Source: